Table 1 Patient sex, diagnosis, and... | American Society of Hematology

Table 1

Patient sex, diagnosis, and array platform used

Patient no.	Sex	Diagnosis	Primary diagnosis	Array pPlatform
1	Female	HL, NS	Yes	Affymetrix
2	Male	HL, MC	Yes	Affymetrix
3	Male	HL, NS	Yes	Affymetrix
4	Male	HL, not specified	No	Affymetrix
5	Male	HL, NS	Yes	Illumina
6	Female	HL, NS	Yes	Illumina
7	Male	HL, NS	Yes	Illumina
8	Female	HL, NS	Yes	Illumina
9	Female	HL, NS	No	Illumina
10	Male	Monocytoid B-cell reaction	Yes	Affymetrix
11	Female	Reactive changes	Yes	Affymetrix
12	Male	Lymphadenitis	Yes	Affymetrix
13	Female	Lymphadenitis	Yes	Affymetrix
14	Male	Reactive changes	Yes	Affymetrix
15	Female	Reactive changes	Yes	Illumina
16	Male	Lymphadenitis	Yes	Illumina
17	Female	Reactive changes	Yes	Illumina
18	Male	Reactive changes	Yes	Illumina
19	Male	FL, grade II	Yes	Affymetrix
20	Male	FL, grade I	No	Affymetrix
21	Male	FL, grade I	Yes	Affymetrix
22	Male	FL, grade I	Yes	Illumina
23	Male	FL, grade I	Yes	Illumina
24	Female	FL, grade II	Yes	Illumina
25	Male	FL, grade I	Yes	Illumina
26	Male	FL, grade II	Yes	Illumina
27	Female	FL, grade I	Yes	Illumina
28	Female	HL, MC; FL in premedical history	No	Illumina
29	Male	B-NHL	Yes	Illumina
30	Male	Reactive changes, proven LP-HD in different LN	No	Illumina

Patient no.	Sex	Diagnosis	Primary diagnosis	Array pPlatform
1	Female	HL, NS	Yes	Affymetrix
2	Male	HL, MC	Yes	Affymetrix
3	Male	HL, NS	Yes	Affymetrix
4	Male	HL, not specified	No	Affymetrix
5	Male	HL, NS	Yes	Illumina
6	Female	HL, NS	Yes	Illumina
7	Male	HL, NS	Yes	Illumina
8	Female	HL, NS	Yes	Illumina
9	Female	HL, NS	No	Illumina
10	Male	Monocytoid B-cell reaction	Yes	Affymetrix
11	Female	Reactive changes	Yes	Affymetrix
12	Male	Lymphadenitis	Yes	Affymetrix
13	Female	Lymphadenitis	Yes	Affymetrix
14	Male	Reactive changes	Yes	Affymetrix
15	Female	Reactive changes	Yes	Illumina
16	Male	Lymphadenitis	Yes	Illumina
17	Female	Reactive changes	Yes	Illumina
18	Male	Reactive changes	Yes	Illumina
19	Male	FL, grade II	Yes	Affymetrix
20	Male	FL, grade I	No	Affymetrix
21	Male	FL, grade I	Yes	Affymetrix
22	Male	FL, grade I	Yes	Illumina
23	Male	FL, grade I	Yes	Illumina
24	Female	FL, grade II	Yes	Illumina
25	Male	FL, grade I	Yes	Illumina
26	Male	FL, grade II	Yes	Illumina
27	Female	FL, grade I	Yes	Illumina
28	Female	HL, MC; FL in premedical history	No	Illumina
29	Male	B-NHL	Yes	Illumina
30	Male	Reactive changes, proven LP-HD in different LN	No	Illumina

NS indicates nodular sclerosis; MC, mixed cellularity; LP-HD, lymphocyte-predominant Hodgkin disease; and LN, lymph node.